{"symbol":"ABT","fiscalQuarter":"Q3-2022","reportDate":"2022-10-19","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q3-2022","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 6.54%","keyNumbers":[{"metric":"EPS","actual":"$1.15","expected":"N/A","surprise":"+26.93%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record for the earnings call, so the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Abbott Laboratories reported a strong EPS that exceeded expectations, but the stock fell by 6.54% in reaction. This decline may reflect investor concerns or broader market trends, as no revenue figures or guidance were provided to clarify future performance.","metaDescription":"Abbott Laboratories (ABT) Q3 2022 earnings: EPS beat by 26.93%. Stock down 6.54%. Full breakdown."}}